A detailed history of Wellington Management Group LLP transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 148,049 shares of ATXS stock, worth $997,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148,049
Previous 147,499 0.37%
Holding current value
$997,850
Previous $1.62 Million 19.65%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$8.81 - $12.1 $4,845 - $6,655
550 Added 0.37%
148,049 $1.3 Million
Q3 2024

Nov 14, 2024

BUY
$8.97 - $12.65 $105,514 - $148,801
11,763 Added 8.67%
147,499 $1.62 Million
Q2 2024

Aug 13, 2024

BUY
$8.83 - $13.51 $173,765 - $265,863
19,679 Added 16.96%
135,736 $1.24 Million
Q1 2024

May 15, 2024

BUY
$6.99 - $16.69 $811,238 - $1.94 Million
116,057 New
116,057 $1.63 Million

Others Institutions Holding ATXS

About Astria Therapeutics, Inc.


  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $102M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.